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The distinct developmental routes of dendritic cells and
mast cells from murine bone marrow cultures with in-
terleukin-3 are unclear.We found that short-term bone
marrow cultures with interleukin-3 after 8^10 d consist
of about 10%^30% dendritic cells and 70%^90% mast
cell precursors, and only after 4^6 wk do homogeneous
populations of mast cells emerge. Phenotypical and
functional analysis of interleukin-3/dendritic cells re-
vealed a high similarity with myeloid dendritic cells
generated with granulocyte-macrophage colony stimu-
lating factor in the expression of myeloid dendritic cell
markers (CD11cþ B220^ CD8a^ CD11bþ ), major histo-
compatibility complex II and costimulatory molecules,
endocytosis, maturation potential, interleukin-12 pro-
duction, and T cell priming. Interleukin-3/dendritic
cells expressed higher levels of interleukin-3 receptor,
however. To dissect the interleukin-3/dendritic cell and
mast cell development, we sorted fresh bone marrow
cells into six subsets by the antibodies ER-MP12
(CD31) and ER-MP20 (Ly-6C). Both interelukin-3/den-
dritic cells and granulocyte-macrophage colony stimu-
lating factor/dendritic cells develop from the same
bone marrow populations, including the ER-MP12neg,
ER-MP20high bone marrow monocytes. In contrast,
mast cells only developed from ER-MP12intþhigh, ER-
MP20neg bone marrow cell subsets, indicating that dif-
ferent precursors exist for interleukin-3/dendritic cells
and mast cells. Established mast cell cultures could not
be converted to dendritic cells or stimulated to express
major histocompatibility complex II molecules in vitro
or home to lymph nodeTcell areas in vivo. In summary,
we show that dendritic cells generated from bone mar-
row precursors with interleukin-3 are clearly myeloid
and develop via a di¡erent pathway compared to bone
marrow mast cells. Key words: bone marrow/dendritic cells/
development/IL-3/mast cells J Invest Dermatol 121:280 ^288,
2003
D
endritic cells (DC) and mast cells (MC) represent
sentinel cells of the immune system, equipped to
defend infectious microbes. Therefore they are pre-
dominantly located in surface tissues such as the
skin or mucosa. Both MC and DC are of bone
marrow (BM) origin.Whereas MC seem to form their own dis-
tinct hematopoietic lineage (Rodewald et al, 1996; Austen and
Boyce, 2001), several DC subsets derived from myeloid, lym-
phoid, and plasmacytoid precursor cells have been described
(Shortman and Liu, 2002).
Interleukin-3 (IL-3) was originally described as a growth factor
stimulating progenitor cells of the myeloid lineage (Ihle, 1992);
only recently has it been reported that it also contributes to lym-
phoid lineage development (Brown et al, 1999). IL-3 has addition-
ally been described as a growth factor for MC.Two major subsets
of MC can be distinguished according to their tissue distribution
and growth requirements. Whereas connective-tissue-type MC
can be generated from murine BM cells in cultures with IL-3
and IL-4 (Tsuji et al, 1990), the mucosal type of MC can be gen-
erated from murine BM cells with IL-3 alone (Nakahata et al,
1986).
The growth requirements for DC are more complex due to
their higher heterogeneity and plasticity during DC develop-
ment. For human DC it has been found that IL-3 promotes the
development of human myeloid DC in vitro (Caux et al, 1996; Eb-
ner et al, 2002). Ex vivo, however, the expression of the IL-3Ra
chain has been attributed as representing a distinctive marker for
human plasmacytoid DC (Grouard et al, 1997; Cella et al, 1999;
Rissoan et al, 1999).
In the mouse, lymphoid-related CD11cþ CD11b^ B220^
CD8aþ DC subsets can be generated with a cocktail containing
IL-3, but not granulocyte-macrophage colony stimulating factor
(GM-CSF), fromTcell precursors in thymus (Saunders et al, 1996;
Kelly et al, 2001) or B cell precursors in the liver (Lu et al, 2001),
which are strictly dependent on IL-3 but not GM-CSF. The gen-
eration of murine CD11cþ CD11b^ B220þ CD8a^ plasmacytoid
DC from BM cells has been shown with Flt3L (Gilliet et al,
2002), whereas isolated plasmacytoid DC from spleens and
lymph nodes show an increased survival on IL-3 (Nakano et al,
2001). Murine plasmacytoid DC also express low amounts of
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IL-3Ra (Asselin-Paturel et al, 2001; O’Kee¡e et al, 2002). The gen-
eration of CD11cþ CD11bþ B220^ CD8a^ myeloid DCwith IL-
3 and a di¡erential analysis of the generation of MC with IL-3
within the same cultures has not been reported so far.
Standard methods using IL-3 as a growth factor for BM liquid
cultures exclusively described the generation of MC, which re-
main the only cell type after 4^6 wk of culture (Hu¡ and Lantz,
1997). Therefore we investigated the lineage origin of IL-3/DC
cultures and compared them with GM-CSF/DC and MC cul-
tures from BM.
Here we show, using the same liquid culture protocol as used
for BM-DC, that DC constitute 10%^30% of the cells that are
generated after 8^10 d of culture with IL-3. Such DC are highly
similar in phenotype and function to myeloid DC generated with
GM-CSF but express the IL-3Ra chain at high levels. IL-3/DC
and MC appear to follow distinct pathways during BM develop-
ment.Together, our data indicate that IL-3 promotes myeloid DC
and MC development but from distinct BM precursors and that
di¡erentiated MC do not convert into DC.
MATERIALS AND METHODS
Cell culture reagents and cytokines For standard cell culture we used
R10 medium, which consisted of RPMI 1640 medium (Boehringer
Ingelheim Bioproducts, Verviers, Belgium) supplemented with 10%
¢ltered fetal bovine serum (PAA, C˛lbe, Germany), 50 mM b-
mercaptoethanol, 100 U per ml penicillin, 100 mg per ml streptomycin,
and 2 mM L-glutamine (all Sigma, Deisenhofen, Germany). In some
experiments serum-free HL-1 medium was used (BioWhittaker Europe,
Verviers, Belgium) supplemented in the same way as R10 without fetal
bovine serum.
Cytokines purchased for use were as follows: IL-3 (100 U per ml), GM-
CSF (200 U per ml), tumor necrosis factor a (TNF-a, 500 U per ml) (all
Peprotech/TEBU, Frankfurt, Germany); lipopolysaccharide (LPS, 1 mg per
ml, Escherichia coli, 0127:B8, Sigma); Staphylococcus aureus Cowan I strain
(SAC, 10 mg per ml, Merck, Darmstadt, Germany). All Animal
experiments have been approved by the German authorities (Regierung
sprsidium Mittelfranken, approval number 621-2631-32-6102).
Mice BALB/c and C57BL/6 mice were either purchased from Charles
River/Wiga (Sulzfeld, Germany) or bred within our own facilities.
TNFR 1 þ 2^/^ mice (on C57BL/6 background, kindly provided by H.
Blˇthmann, Roche, Basel, Switzerland) were used to compare allo-mixed
leucocyte reaction activity of GM-CSF/DC with IL-3/DC.
Isolation of BM cells and generation of BM-DC The isolation of
BM cells and the generation of murine BM-DC with GM-CSF has been
described extensively before (Lutz et al, 1999). IL-3/DC were prepared
similarly but using IL-3 instead of GM-CSF. Cells were fed at days 3 and
6, and analyzed at day 8, as described.
Flow cytometry Cells (2105) were stained with 50 mL hybridoma
culture supernatants containing 0.1% sodium azide or directly conjugated
¢rst and second step antibodies at 5^20 mg per ml for 30 min on ice.
Primary and secondary antibodies were diluted in phosphate-bu¡ered
saline containing 5% fetal bovine serum and 0.1% sodium azide, which
also served as washing medium. For cytoplasmic staining, cells were ¢xed
with 1% formaldehyde and the staining was performed in the presence
of 0.5% saponin (Sigma). Fluorescence analysis was performed with a
FACScan (Becton Dickinson). The following antibodies were used as
hybridoma cell culture supernatants (sup) or puri¢ed antibodies (pure)
for surface and cytoplasmic staining: IL-3Ra (pure, CD123, 5B11,
Pharmingen), CD86 (pure, anti-B7-2, GL1, Pharmingen), CD117 (pure, c-
kit, 2B8, Pharmingen), CD14 (pure, Pharmingen), 2A1 (intracellular, sup),
B220 (pure, Pharmingen), T cell receptor ab (TCR-ab, H57-597, sup),
CD8a (pure, 53-6.7, Pharmingen), CD11b (M1/70, sup), CD11c (N418,
sup), CD13 (ER-BMDM-1, sup), CD205 (NLDC145, sup), followed by
antihamster-£uorescein isothiocyanate (FITC) or antirat-FITC antibodies
(both Pharmingen) and phycoerythrin (PE) conjugated anti-major
histocompatibility complex (MHC) class II (M5/114), or CD11c-PE
or CD11c-FITC (Pharmingen). Isotype controls were rat IgG2a
(MAC3AFRC, sup, or PE-conjugated R35-95, Pharmingen), rat IgG2b
(Lo-DNP11, sup), hamster IgG (pure, G235-2356, anti-TNP,
Pharmingen). Staining for the high a⁄nity FceR I was performed by
incubating cells for 1 h at 41C with 10 mg per ml mouse IgE-anti-DNP
(Sigma, clone SPE-7). During the last 30 min 10 mg per ml FITC-
conjugated rat-antimouse IgE (Pharmingen) was added. Detection of
apoptotic cells was performed with an Annexin V FITC kit (BenderMed
Systems,Vienna, Austria) according to the manufacturer’s descriptions.
Endocytosis GM/DC and IL-3/DC were cultured until day 10. Then,
2105 DC were incubated with 1 mg per ml FITC-conjugated dextran,
FITC-conjugated ovalbumin, or Lucifer Yellow (all Molecular Probes,
Leiden, The Netherlands) for 0, 15, 30, 60 min on ice or at 371C. Then all
samples were double stained with PE-conjugated 2G9 (anti-MHC class II)
monoclonal antibodies before £uorescence-activated cell sorter (FACS)
analysis. Mean £uorescence values within the gate for endocytically active
immature DC were plotted as described previously (Lutz et al, 1997).
In vitro and in vivo priming For in vitro primary allogeneic mixed
leucocyte reaction, BM cells from female TNFR 1 þ 2^/^ mice were
cultured until day 9 under standard conditions with either GM-CSF or
IL-3 and treated with LPS for 24 h. GM-CSF/DC generated from wild-
type mice produced higher percentages of spontaneously mature DC in
culture than IL-3/DC, due to endogenous TNF-a production in the
cultures with GM-CSF (Yamaguchi et al, 1997). Therefore TNF-a-
unresponsive BM-DC from TNFR 1 þ 2^/^ mice were used to generate
exclusively immature DC from both GM-CSF and IL-3 cultures, which
still have the capacity to mature upon LPS stimulation. For the allo-
mixed leucocyte reaction the cells were harvested at day 8, washed, and
transferred into a 96-well £at-bottomed plate (Becton Dickinson) at
titrated numbers together with CD4þ T cells (BALB/c, 3105 cells per
well) derived from pooled lymph nodes and puri¢ed using Cellect mouse
CD4 cell-enrichment columns (TEBU, Frankfurt, Germany). After 3 d,
triplicate cultures were pulsed with 1 mCi [3H]-thymidine (Amersham)
for 16 h and harvested onto ¢ltermats with an ICH-110 harvester (Inotech,
Dottikon, Switzerland); ¢lters were counted in a 1450 Microplate Counter
(Wallac,Turku, Finland).
For in vivo priming with allogeneic BM-DC, BM cells from BALB/c
mice were cultured until day 9 with either IL-3 or GM-CSF.
Nonadherent cells were injected subcutaneously into each hind footpad of
female C57BL/6 mice (105 per 50 mL phosphate-bu¡ered saline per
footpad). After 8 d the popliteal and inguinal lymph nodes were
removed. From the single cell suspension of the lymph node cells, 4105
cells per well were seeded into a 96-well £at-bottomed plate (Becton
Dickinson) and restimulated with mitomycin-C-treated (Sigma) BALB/c
spleen cells at titrated numbers. After 3 d the triplicate cultures were
pulsed with 1mCi [3H]-thymidine (Amersham) and harvested as described
above.
In vivo migration of £uorescent MC BM-MC were cultured for 4 wk
and then labeled with 5 mM carboxy£uorescein (Molecular Probes) for 15
min at room temperature. MC were washed and injected subcutaneously
(2106 cells per footpad) or intravenously (1107 cells). After 24 h
popliteal lymph nodes or the spleen, respectively, were removed.
Cryosections were stained with 3D6 antibody recognizing sialoadhesion
CD169 (kindly provided by L. Martinez-Pomares and S. Gordon, Oxford,
UK), followed by an antirat PE-conjugated secondary antibody
(Pharmingen) to mark the subcapsular sinus of the lymph nodes or the
marginal zone of the spleen.
IL-12 production BM cells from female BALB/c mice were cultured
until day 8 either with IL-3 or GM-CSF, and then harvested and washed;
1106 cells per well were transferred into a bacteria-quality 24-well plate
(Becton Dickinson), and stimulated with SAC7 interferon-g (IFN-g, 100
U per ml, Pharmingen) 7 LPS. After 48 h supernatants were analyzed
for IL-12 p70 by ELISA by using an Opti EIA Mouse IL-12 p70
kit (Pharmingen). Analysis of intracellular IL-12 p40 production was
performed with a Cyto¢x/Cytoperm Plus Kit (Pharmingen) according to
the manufacturer’s instructions. Cells were double stained with PE-
conjugated CD11c (N418) or MHC II (M5/114) monoclonal antibody to
gate on DC and non-DC before analysis by FACS.
Cell sorting Fresh BM cells were stained for CD31 (ER-MP12) and Ly-
6C (ER-MP20) expression as described previously (de Bruijn et al, 1994)
and cells within the indicated gates were sorted with a MoFlo high speed
cell sorter (Cytomation Bioinstruments, Freiburg, Germany). Sorted BM
subpopulations were cultured with IL-3 or GM-CSF for 8 d or 3 or 5 wk
before the nonadherent cells were analyzed by FACS.
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RESULTS
Simultaneous generation of DC and MC in short-term BM
cultures supplemented with IL-3 BM cells are supposed to
develop into MC after culture in IL-3 within a time period of
about 4 wk. Here we cultured BM cells in IL-3 for 8 d and
analyzed them for their morphology and by £ow cytometry. A
large proportion of cells at day 8 were already positive for
CD117 (Fig 1a) and the high a⁄nity FceR I (not shown),
indicating the development of MC. Cytospin preparations of
such cells showed the typical granular staining for MC with
May^Grˇnwald^Giemsa reagent (Fig 1b).
It has been described that MC can acquire MHC II expression
under certain culture conditions using GM-CSF and IL-4
(Frandji et al, 1993; 1995). At this early time of day 8 BM culture
in IL-3, a substantial proportion of cells was positive for MHC II,
and only some of them coexpressed low amounts of CD117 or
FceR I (Fig 1a).When we double stained these MHC IIþ cells
for DC markers we found them positive for CD11c (Fig 1a),
CD14, and for intracellular 2A1 (not shown). The CD11cþ DC
did not express B220, CD8a, or CD205, but CD11b, partially
Gr-1, and CD13, indicating that they are myeloid DC and not
lymphoid DC (Henri et al, 2001) or plasmacytoid DC (Hochrein
et al, 2002) (Fig 1a). This expression pattern is nearly identical to
myeloid DC that are generated from BM with GM-CSF
(Lutz et al, 1999). A clear di¡erence between IL-3/DC and
myeloid GM-CSF/DC was observed regarding their expression
of the IL-3Ra chain, which was almost absent on GM-CSF-
derived BM-DC but clearly expressed on DC generated with
IL-3. IL-3Ra chain expression by IL-3-derived DC is
comparable to that on mature MC from a 4-wk-old culture
generated with IL-3 (Fig 1c).
In the following experiments we wanted to substantiate the
presumed DC identity of the cells obtained from IL-3-
stimulated cultures by assessing major DC functions such as
endocytosis, maturation capacity, IL-12 production, and T cell
priming and homing.
The endocytosis capability of immature IL-3/DC is
comparable to that of GM-CSF/DC Immature myeloid DC
in vivo reside in peripheral tissues as sentinels awaiting the
penetration of microorganisms. DC at this developmental stage
bear multiple receptor-dependent and receptor-independent
mechanisms to take up foreign antigens. These antigens are
processed intracellularly and are subsequently transported to the
T cell areas of the draining lymph nodes for antigen presentation
(Banchereau and Steinman, 1998). Two of the best studied
mechanisms of DC endocytosis are macropinocytosis and
mannose-receptor-mediated uptake of £uorescence-labeled
tracers, such as Lucifer Yellow and FITC-ovalbumin or FITC-
dextran, respectively (Sallusto et al, 1995; Lutz et al, 1996; 1997).
When we compared the level of antigen uptake of these tracers
by GM-CSF/DC and IL-3/DC no di¡erences were found (Fig
2). Also the phagocytic activity of FITC-conjugated latex beads
was comparable (not shown).
Phenotypical and morphologic maturation of IL-3/
DC DC mature upon contact with proin£ammatory stimuli,
microbial products from viruses or bacteria, or CD40 signals
from T cells, which results in upregulation of MHC and
costimulatory molecules (Banchereau and Steinman, 1998).
When IL-3/DC cultures were kept in IL-3 alone, only very few
CD11cþ MHC IIhigh expressing cells, representing mature DC,
were detectable. The CD11cþ cells also did not express CD40 or
CD86, and very little CD80 (Fig 3a, ctrl). A mild maturation of
IL-3/DC could be induced, however, by stimulation withTNF-a
and all markers were clearly upregulated by LPS (Fig 3a). The
maturation of DC was con¢rmed by the induction of dendritic
morphology, which was again mild with TNF-a but very strong
with a SAC preparation (Fig 3b).
IL-3/DC and GM-CSF/DC are similarly potent to produce
IL-12 p40 and p70 after stimulation DC can be stimulated
to secrete cytokines such as IL-12, which promotes polarization
of T helper cells towards the Th1 direction (Cella et al, 1996;
Koch et al, 1996; Vieira et al, 2000). There has been ample
discussion about the superiority of human plasmacytoid IL-
3Raþ DC versus myeloid monocyte-derived DC or murine
lymphoid-related CD8aþ versus myeloid CD8a^ DC in their
capability to produce IL-12 (summarized in Moser and Rock,
2000).When we tested our myeloid GM-CSF/DC and IL-3/DC
for IL-12 p40 production by intracellular FACS staining we
found that only a fraction of the CD11cþ GM-CSF-cultured
cells but none of the CD11c^ cells produced IL-12 p40 (Fig 4a).
Further analysis revealed that only the mature MHC IIhigh,
CD11cþ GM-CSF/DC were responsible for the IL-12 p40
production (Fig 4b). Interestingly, in the IL-3-stimulated
cultures both the CD11cþ and CD11c^ subpopulations produced
IL-12 p40 (Fig 4a). Both IL-3/DC and GM-CSF/DC were also
stimulated with SAC alone or in combination with IFN-g or
IFN-g þ LPS to induce bioactive IL-12 p70. Whereas
ELISA supernatants from SAC or SAC þ IFN-g stimulated
cells contained comparable amounts of IL-12 p70 for both
IL-3/DC and GM-CSF/DC, IL-3/DC were superior to GM-
CSF/DC when the triple cocktail SAC þ IFN-g þ LPS was
used (Fig 4c).
IL-3/DC but not MC facilitate homing to the lymph node T
cell areas and priming of allogeneic T cells IL-3/DC and
GM-CSF/DC were tested for their potential to stimulate
allogeneic CD4þ T cells in vitro. To eliminate the e¡ects of
endogenously produced TNF on immature and LPS-matured
stages of GM-CSF/DC and IL-3/DC, BM-DC were generated
from TNFR 1 þ 2^/^ mice (see also Materials and Methods).
Unstimulated IL-3/DC were slightly weaker stimulators of T
cell proliferation than GM-CSF/DC, but when both DC types
were pretreated with LPS the T cell proliferation was comparable
(Fig 5a).
A prerequisite for T cell priming in vivo is the ability of the
antigen presenting cell to migrate into the T cell areas of
lymphoid organs. When IL-3/DC or GM-CSF/DC (C57Bl/6)
were injected subcutaneously into allogeneic mice (BALB/c) and
the draining lymph node cells were restimulated after 10 d with
the same allotype of spleen cells as used for the priming (C57Bl/
6), an increased proliferation of draining lymph node cells was
observed in mice that were preinjected with IL-3/DC or GM-
CSF/DC (Fig 5b). Although GM-CSF/DC were superior in T
cell stimulation in vivo, a clear priming e¡ect was also observed
with IL-3/DC.
Although MC have been shown to migrate into lymph nodes
in vivo (Wang et al, 1998), we found that £uorescence-labeled MC
do indeed enter the lymph nodes but cannot reach the T cell
areas. MC remain in the subcapsular sinus of the lymph nodes
after subcutaneous injection and the red pulp of the spleen after
intravenous injection (Fig 5c), indicating that they are not
involved in antigen presentation toT cells in vivo.
Taken together, we generated DC from BM precursor
cells with IL-3 that show phenotypical and functional
characteristics highly similar to those described for BM-DC
generated with GM-CSF (Inaba et al, 1992; Scheicher et al, 1992;
Lutz et al, 1999).
IL-3/DC and MC develop from di¡erent progenitor cells in
BM Using IL-3 in BM cultures DC and MC were generated
simultaneously. DC development stimulated by IL-3 reaches the
highest proportion of DC around day 9 or 10 of culture (not
shown) equivalent to GM-CSF/DC (Lutz et al, 1999). MC
development continues for more than 8 wk and ends with a
highly pure MC population after 4^6 wk because other primary
BM cell types do not survive for such an extended period of
culture (Lantz et al, 1997, and our own observations).
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Therefore, we addressed the question whether there is a
common progenitor for IL-3/DC and MC. Two markers have
been described to follow the development of BM cells from the
earliest stem cells to enriched subsets for committed erythroid,
lymphoid, granulocytic, and macrophage/DC development (de
Bruijn et al, 1994; Nikolic et al, 2003).When fresh BM cells were
double stained with the antibodies ER-MP12 (CD31, PECAM-1)
and ER-MP20 (Ly-6C) six distinct populations could be detected
(Fig 6a). The ER-MP12neg/20high region (Fig 6a, R6) contains
BM monocytes, which show restricted development into
Figure1. Simultaneous generation of MC and IL-
3Raþ DC in BM cultures supplemented with IL-
3. BM cells were cultured for 8 d with IL-3. (a) Double
stainings were performed for MHC II versus TCR-ab
(negative control) and CD11c, or for CD11c versus the
indicated markers. (b) MC and their precursors within
the cultures could be identi¢ed by their cytoplasmic
granularity visible after MayGrˇnwaldGiemsa
staining of a cytospin preparation (original magni¢ca-
tion 1000 ). (c) DC were generated with IL-3 and
GM-CSF until day 8 and pure MC were generated by
culture with IL-3 for 4 wk and then analyzed for
CD123 (IL-3Ra) expression. Day 8 cultures were gated
on MHC IIþ cells.
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macrophages and DC when cultured in GM-CSF, whereas ER-
MP12neg/20int cells (Fig 6a, R5) represent exclusively
neutrophilic polymorphonuclear granulocytes (de Bruijn et al,
1994, and our own unpublished observations). Here we sorted
fresh BM cells within the same gates (ER-MP12neg/20high and
ER-MP12neg/20int) and cultured them with IL-3, or as a control
with GM-CSF. As described, the cells cultured with GM-CSF for
8 d developed into DC and macrophages (Fig 6b, from R6) and
MHC II^ CD11c^ cells, most probably granulocytes (Fig 6b, from
R5), respectively. In contrast, with IL-3 no cells grew within the
granulocyte gate (Fig 6b, from R5, ER-MP12neg/20int), but equal
amounts of DC could be generated from the ER-MP12neg/20high
population (Fig 6b, from R6).
To address whether BM monocytes might represent common
precursors for IL-3/DC and MC, the same BM population that
gives rise to IL-3/DC (cells within R6 of Fig 6a) was sorted for
ER-MP12neg/20high (R6) and cultured for 3 wk. All DC had died
in cultures with IL-3 and, as known, with GM-CSF. Only
adherent macrophages remained, but no nonadherent MC could
be detected. This shows that DC develop from di¡erent
precursors within the BM than MC, although both respond to
IL-3.
It remained to be established which region R1R4 would give
rise to MC after culture for more than 4 wk in IL-3. Therefore
fresh BM cells were stained for ER-MP12/20 and the cells
within the regions R1R4 were sorted and cultured in IL-3 for
38 d. Only the cells within the regions R1 and R2 developed
into MC (Fig 7a, b), whereas cells sorted from the regions R3
and R4 had all died after this time. DC could be generated with
GM-CSF or IL-3 after 8 d from the regions R1, R2, and R4 (Fig
7c, d). As shown recently for GM-CSF-stimulated DC cultures
(Nikolic et al, 2003), the regions R1 and R4 may be considered
Figure 2. Endocytosis capacities of IL-3/DC and GM-CSF/DC. BM
cells were cultured with GM-CSF or IL-3 for 8 d. Macropinocytosis was
analyzed with Lucifer Yellow and FITC-ovalbumin, and mannose-recep-
tor-mediated uptake with FITC-dextran, after 0, 15, 30, and 60 min; cells
were double stained with MHC II. The mean £uorescence values of MHC
IIlow expressing immature DC are shown.
Figure 3. Maturation of IL-3/DC measured by MHC II and B7-2 expression and acquisition of veiled morphology. BM cells were cultured with
IL-3 until day 8 and then stimulated overnight with the indicated reagents. (a) FACS analysis for CD11c versus MHC II and histograms gated on CD11cþ
cells of the markers CD40, CD80, and CD86 of unstimulated cells (ctrl) or TNF- or LPS-stimulated cells are shown (straight lines), with isotype stainings as
overlays (dotted line). Numbers within the dot plots represent percentages of mature DC within the quadrants. (b) Phase contrast photographs were taken
from untreated cultures with IL-3 alone (IL-3) or with the indicated stimuli. Original magni¢cation 400 .
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as the major sources for DC development also for IL-3-
stimulated cultures. In our experiments, R2 cells also generated
some DC in cultures with GM-CSF or IL-3. Given the low
yields from this fraction, however, we cannot completely rule
out R1 contamination. For the development of MC the cells
from region R1 also show a higher expansion potential than R2
cells. The region R1 represents the source of the earliest myeloid
progenitor cells responsive to GM-CSF before they develop into
R4 and ¢nally R6 (de Bruijn et al, 1994; Nikolic et al, 2003). R2 is
known to contain the earliest hematopoietic stem cells with long-
term repopulating activity in vivo (van der Loo et al, 1995).
Together, DC development with IL-3 from BM cells could be
observed mainly from the populations R1, R4, and R6, and
possibly to a limited extent from R2. MC can predominantly
be derived from cells within the region R1 and less e¡ectively
from R2. This might indicate that DC and MC derive from the
same pool of early GM-CSF- or IL-3-responsive cells, but DC
follow di¡erent routes of di¡erentiation within the BM as
followed with the markers ER-MP12 (CD31) and ER-MP20
(Ly-6C). DC development from the di¡erent regions seems to
follow the same routes, however, whether the subsets are
cultured with GM-CSF or IL-3.
MC do not convert into DC To test whether established MC
cultures can develop into DC, an 8-wk-old BM-MC culture was
washed and recultured in IL-3, GM-CSF, or GM-CSF plus IL-4
for 2 and 11 d. No MHC II or CD11c DC marker expression
could be detected in such MC cultures, however, and the MC
showed increased signs of apoptosis (annexin Vþ ) in cultures
without IL-3 (Fig 8).
DISCUSSION
Only the development of MC has been reported so far when
murine BM cells are cultured with IL-3 (Nakahata et al, 1986;
Hu¡ and Lantz, 1997). Therefore we investigated whether murine
BM cultures supplemented with IL-3 can also give rise to DC,
and what their lineage origin and relation to MC might be.
Early day 8^10 BM cultures with IL-3 contain around 70%
MC or their precursor stages but also about 30% MHC IIþ
CD11cþ cells that coexpress typical myeloid BM-DC markers
such as CD11b, CD14, and low amounts of CD13, Gr-1, and in-
tracellular 2A1 (not shown), similarly to GM-CSF/DC (Lutz et al,
1999). In contrast, the lymphoid DC markers CD8a and CD205
as well as plasmacytoid DC marker B220 are not expressed.
Other typical features of myeloid DC, such as endocytosis, ma-
turation potential, IL-12 production, and T cell priming and
homing in vivo were also comparable to myeloid DC that have
been generated with GM-CSF, as described previously (Lutz et al,
1999). The only clear di¡erence to GM-CSF/DC is that IL-3/DC
express higher levels of CD123, the IL-3Ra chain. Therefore
our data strongly argue for the generation of CD11cþ CD11bþ
B220^ CD8a^ myeloid DC in early day 8^10 cultures
with IL-3.
Previously, it has been reported that MC from IL-3-stimulated
BM cultures could be induced by GM-CSF or GM-CSF plus IL-
4 to express MHC II and costimulatory molecules and therefore
these cells could be used as professional antigen presenting cells in
vitro (Frandji et al, 1993; 1995;Tkaczyk et al, 2000) and in vivo (Villa
et al, 2001). In contrast, we found that pure cultures of BM-MC,
which were only obtained after 6^8 wk of culture, could not be
induced to express MHC II molecules or develop into CD11cþ
cells upon culture in GM-CSF or GM-CSF plus IL-4. In vivomi-
gration of MC during immune responses can occur from periph-
eral organs into the lymph nodes of mice (Wang et al, 1998).We
also observed MC entering the lymph nodes or spleen, but they
did not reach the T cell areas, but rather remained in the subcap-
sular sinus of lymph nodes or red pulp of the spleen. Conse-
quently, MC also could not induce allogeneic T cell priming in
vivo (not shown). Short-term day 8 BM cultures with IL-3, how-
ever, which contain IL-3/DC, could readily induce allogeneic T
cell priming in vivo. Based on these data, we argue that MC can-
not act as professional, migrating antigen presenting cells, but
that BM-MC cultures might be contaminated by IL-3/DC,
which then exert these functions.
A remarkable di¡erence between the IL-3- and GM-CSF cul-
tures is that IL-3/DC developed together with MC, whereas GM-
CSF/DC grow in concert with neutrophils (Lutz et al, 1999). In
our cultures IL-3 seems to promote the development of DC and
MC with di¡erent kinetics, as DC are detectable at maximal
Figure 4. IL-3/DC and GM-CSF/DC produce similar amounts of
IL-12. (a), (b) BM cells were cultured with IL-3 or GM-CSF until day 8
and then incubated overnight with cytoperm solution and LPS for cyto-
kine production. Then, the cells were ¢xed and stained intracellularly for
IL-12 p40 (continuous line) or an isotype control monoclonal antibody
(dotted line) and on the surface for CD11c. (a) Histograms for IL-12 p40
staining of gated CD11cþ and CD11c^ cells. Both subsets produce IL-12
p40. (b) GM-CSF/DC were double stained for MHC II, indicating that
only the most mature DC (MHC IIhigh) produce IL-12 p40. (c) IL-3/DC
and GM-CSF/DC were cultured until day 8 and then stimulated with
SAC alone or in combination with LPS and IFN-g to detect IL-12 p70
after 48 h by ELISA.
DENDRITIC CELLS GENERATEDWITH IL-3 285VOL. 121, NO. 2 AUGUST 2003
levels around days 8^10 and MC around 4^8 wk. To address the
question of a lineage relation between IL-3/DC and MC, we
sorted BM cells into six populations by the markers ER-MP12
and ER-MP20. MC development was more restricted than IL-3/
DC development, as MC grew only from the sorted ER-MP12/
20 populations R1 and R2, whereas IL-3/DC could be generated
additionally from R4 and R6 cells, similar to GM-CSF/DC.This
argues against a close lineage relationship between later myeloid
stages of IL-3/DC and MC, but does not exclude a common
early progenitor within BM. For myeloid DC development one
might speculate whether an early myeloid progenitor is equally
responsive to IL-3 or GM-CSF.
A physiologic role for the overlapping functions of IL-3 on the
generation of DC and MC even from separate lineages remains
unclear so far. Neutrophil generation is promoted by GM-CSF,
as is the development of DC and macrophages. Functionally,
neutrophil mobilization is associated withTh1 immune responses,
whereas MC activation is observed during allergic responses and
Th2 immunity. Studies investigating IL-3^/^ mice revealed that
IL-3 is not essential for MC and basophil generation, but certain
types of immune responses were impaired, such as delayed-type
Figure 5. Capacities of T cell priming by DC generated in IL-3 or
GM-CSF and MC homing. (a) IL-3/DC and GM-CSF/DC were gener-
ated fromTNFR 1 þ 2 double de¢cient mice (see Materials and Methods).
Unstimulated and LPS-stimulated DC were cocultured with allogeneic T
cells for 3 d before proliferation was assessed. Error bars represent standard
deviations. The ¢gure is representative for four independent experiments.
(b) IL-3/DC and GM-CSF/DC were generated from C57/BL6 mice until
day 8, and then 2  105 DC were injected subcutaneously into BALB/c
mice. Draining lymph node cells of not injected and DC-injected mice
were restimulated with allogeneic spleen cells (C57/BL6) in vitro and prolif-
eration tested after 3 d. Error bars represent standard deviations. The ¢gure
is representative for three independent experiments. (c) MC were cultured
for 6 wk in IL-3, labeled with the £uorescent tracer carboxy£uorescein, and
then injected subcutaneously into the hind footpads or intravenously into
syngeneic mice. After 24 h draining lymph nodes or spleen were removed
and cryosections were stained with 3D6 antibody, marking the subcapsular
sinus (SS) but not paracortical T cell areas (p), or the marginal zone (MZ)
but not the red pulp (RP) or white pulp (WP), respectively. Green
cells indicate migrated MC (also by arrows). Original magni¢cations
were 200 or 400 . The ¢gure is representative for two independent
experiments.

Figure 6. IL-3/DC and GM-CSF/DC but not MC derive from the
same late BM precursor cell population. (a) Fresh BM cells were sorted
for CD31neg Ly-6C intermediate and high expressing cells indicative for
restricted granulocyte (R5) and macrophage/DC development (R6), and
5  105 cells per well were cultured with GM-CSF. (b) FACS analysis of
cells cultured with IL-3 and GM-CSF to detect DC (after 8 d). Double
staining was performed for MHC II and CD11c to detect DC. Numbers
within the quadrants represent percentages of cells. Numbers below the
dot plots represent the total cell yields at day 8. No nonadherent cells could
be detected from cells sorted from R5 and cultured with IL-3 (after 8 d or
3 wk) and from R6 with GM-CSF after 3 wk.
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hypersensitivity reactions (Mach et al, 1998) and immune re-
sponses to parasites (Lantz et al, 1998). Given the fact that DC co-
localize with MC in surface organs such as the skin where
infections take place, IL-3 might exert additional functions also
on DC. This fact needs now further evaluation in delayed-type
hypersensitivity reactions or infection models.
Although both GM-CSF/DC and IL-3/DC can be induced to
secrete Th1 polarizing IL-12 in vitro, a cellular cooperation
between DC and neutrophils or DC and MC might polarize to-
wards Th1 or Th2, respectively. For human DC cultured with
IL-3 plus IL-4 it has been reported that such cells rather
polarize for Th2 responses (Ebner et al, 2002). This topic of
DC instruction for Th polarization (Kalinski et al, 1999) and
the role of MC in in£uencing this process are currently under
investigation.
Taken together, we described the simultaneous generation of
DC and MC from murine BM cultures by IL-3. Given the fact
that these two cell types colocalize preferentially in surface organs
such as the skin, IL-3 might play a dual role on DC and MC for
the induction of Th2 responses such as allergies.
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Figure 7. MC development from BM is more restricted than IL-3/
DC development. Fresh BM cells were stained with ER-MP12 and ER-
MP20 antibodies as in Fig 6, and the sorted populations within regions R1,
R2, R3, and R4 were cultured for 8 or 38 d with a starting cell number of
1.5  105 per culture. (a), (b) MC could only be generated from sorted cells
within the R1 and R2 regions as detected by MayGrˇnwaldGiemsa
staining of cytospins. (b) DC development was analyzed after 8 d and de-
tected by staining for MHC II and CD11c, analyzed by FACS. From R3 no
DC could be generated. Large numbers within the dot plots represent per-
centages of cells within the respective quadrants; small numbers indicate
the total cell number yielded from the cultures at day 8 or day 38.

Figure 8. Terminally di¡erentiated MC cannot be induced to ex-
press MHC II or convert to CD11cþ DC with GM-CSF 7 IL-4.
Cultures of pure MC after 8 wk were left in IL-3 or washed and cultured
in GM-CSF or GM-CSF7 IL-4 for 2 or 11 d.Then cells were analyzed by
FACS for MHC II and CD11c expression to detect DC and annexin V
binding to detect apoptosis.
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